DRMA DERMATA THERAPEUTICS INC
FollowCOM (common), issuer CIK 1853816
7 managers (7 13F filers) reported a position in DRMA shares at 2025-12-31, 26,892 shares in all. 3 filers opened a position and 1 filer sold out during the quarter.
- Managers
- 7
- 13F filers
- 7
- New
- 3
- Added
- 2
- Reduced
- 1
- Sold out
- 1
- Shares held by filers
- 26,892
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q4 2025
Filers in the available 13F reports with a share position at 2025-12-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| Clear Street Group Inc.in group Clear Street Group Inc. | 17,000 | $39.4K | <0.01% | new | 13F-HRTimelineGroup |
| BANK OF AMERICA CORP /DE/in group BANK OF AMERICA CORP /DE/ | 3,457 | $8.02K | <0.01% | +3,453 | 13F-HRTimelineGroup |
| BARCLAYS PLCin group BARCLAYS PLC | 2,402 | $5.57K | <0.01% | new | 13F-HRTimelineGroup |
| Tower Research Capital LLC (TRC)in group Tower Research Capital LLC (T… | 1,999 | $4.64K | <0.01% | +1,573 | 13F-HRTimelineGroup |
| UBS Group AGin group UBS Group AG | 1,237 | $2.87K | <0.01% | -8,810 | 13F-HRTimelineGroup |
| JPMORGAN CHASE & COin group JPMORGAN CHASE & CO | 696 | $1.61K | <0.01% | new | 13F-HRTimelineGroup |
| SBI Securities Co., Ltd. | 101 | $234 | <0.01% | 0 | 13F-HRTimeline |